Free Trial
NASDAQ:NEOG

Neogen (NEOG) Stock Price, News & Analysis

$17.33
+0.31 (+1.82%)
(As of 07/26/2024 ET)
Today's Range
$17.12
$17.61
50-Day Range
$13.15
$17.71
52-Week Range
$11.46
$24.09
Volume
1.84 million shs
Average Volume
2.09 million shs
Market Capitalization
$3.75 billion
P/E Ratio
1,734.73
Dividend Yield
N/A
Price Target
$22.50

Neogen MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
29.8% Upside
$22.50 Price Target
Short Interest
Bearish
11.44% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.90mentions of Neogen in the last 14 days
Based on 7 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
21.74%
From $0.46 to $0.56 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.30 out of 5 stars

Medical Sector

574th out of 936 stocks

Diagnostic Substances Industry

9th out of 15 stocks

NEOG stock logo

About Neogen Stock (NASDAQ:NEOG)

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

NEOG Stock Price History

NEOG Stock News Headlines

625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
Neogen (NEOG) Scheduled to Post Earnings on Tuesday
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
Neogen Corporation: Challenges Remain
See More Headlines
Receive NEOG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neogen and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/09/2024
Today
7/26/2024
Next Earnings (Confirmed)
7/30/2024
Fiscal Year End
5/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostic substances
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:NEOG
CUSIP
64049110
Employees
2,640
Year Founded
1982

Price Target and Rating

Average Stock Price Target
$22.50
High Stock Price Target
$28.00
Low Stock Price Target
$17.00
Potential Upside/Downside
+29.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$-22,870,000.00
Pretax Margin
-0.03%

Debt

Sales & Book Value

Annual Sales
$822.45 million
Cash Flow
$0.94 per share
Book Value
$14.49 per share

Miscellaneous

Free Float
215,070,000
Market Cap
$3.75 billion
Optionable
Optionable
Beta
1.20

Social Links

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

NEOG Stock Analysis - Frequently Asked Questions

How have NEOG shares performed this year?

Neogen's stock was trading at $20.11 on January 1st, 2024. Since then, NEOG shares have decreased by 13.8% and is now trading at $17.33.
View the best growth stocks for 2024 here
.

How were Neogen's earnings last quarter?

Neogen Co. (NASDAQ:NEOG) posted its earnings results on Tuesday, April, 9th. The company reported $0.12 EPS for the quarter, missing analysts' consensus estimates of $0.14 by $0.02. The business's revenue for the quarter was up 4.8% on a year-over-year basis.

When did Neogen's stock split?

Neogen shares split on Tuesday, January 2nd 2018. The 4-3 split was announced on Friday, December 8th 2017. The newly created shares were issued to shareholders after the market closes on Friday, December 29th 2017. An investor that had 100 shares of stock prior to the split would have 133 shares after the split.

What is John Adent's approval rating as Neogen's CEO?

31 employees have rated Neogen Chief Executive Officer John Adent on Glassdoor.com. John Adent has an approval rating of 56% among the company's employees. This puts John Adent in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are Neogen's major shareholders?

Top institutional shareholders of Neogen include Baillie Gifford & Co. (5.35%), Conestoga Capital Advisors LLC (3.23%), Banque Pictet & Cie SA (1.22%) and Bank of New York Mellon Corp (0.90%). Insiders that own company stock include John Edward Adent, Douglas Edward Jones, Steven J Quinlan, David H Naemura, Jason Warren Lilly, William T Boehm, James C Borel, James P Tobin, Ronald D Green and Darci L Vetter.
View institutional ownership trends
.

How do I buy shares of Neogen?

Shares of NEOG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Neogen own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Neogen investors own include NVIDIA (NVDA), NIKE (NKE), Pfizer (PFE), AT&T (T), AbbVie (ABBV), Boeing (BA) and JPMorgan Chase & Co. (JPM).

This page (NASDAQ:NEOG) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners